Form 4 for LNAI Lunai Bioworks Inc.
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0001731122-24-000292 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-02-22 | 2024-02-20 | LNAI | Sindlev Rene | Dir, 10% | X - OptEx | $0.53 | +471.7K | 13.61M | +4% | +$250.0K |
| DI | 2024-02-22 | 2024-02-20 | LNAI | Sindlev Rene | Dir, 10% | X - OptEx | $0.00 | -471.7K | 471.7K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | X | A | 471,699 | $0.53 | 13,605,297 | I By RS Bio ApS | — | — | |
| 2 | Derivative | Warrant (Right to Buy) | 2024-02-20 | X | D | 471,699 | $0.00 | 471,698 | I By RS Bio ApS | $0.53 · 2023-06-26 to 2028-06-26 | 471,699 Common Stock |